Company Filing History:
Years Active: 2003-2010
Title: The Innovations of Judd W. Moul
Introduction
Judd W. Moul is a prominent inventor based in Bethesda, MD (US), known for his significant contributions to the field of prostate cancer research. With a total of 4 patents, Moul has developed innovative methods and technologies aimed at improving the detection, treatment, and prevention of prostate-related diseases.
Latest Patents
Moul's latest patents include groundbreaking work on the prostate-specific gene, PCGEM1. This invention discloses a nucleic acid sequence that exhibits prostate-specific expression and over-expression in tumor cells. The sequence and its fragments are instrumental in detecting, diagnosing, preventing, and treating prostate cancer and other prostate-related diseases. Additionally, Moul has developed methods for measuring hormone responsiveness in prostate cancer cells. Another notable patent involves the androgen-regulated PMEPA1 gene and its encoded proteins, including variants and analogs. This invention also encompasses other androgen-regulated nucleic acids and a polynucleotide array that can be utilized in the diagnosis and prognosis of prostate cancer.
Career Highlights
Judd W. Moul is affiliated with The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., where he continues to advance his research and innovations in the medical field. His work has had a profound impact on understanding prostate cancer and developing new therapeutic strategies.
Collaborations
Moul has collaborated with esteemed colleagues such as Shiv Srivastava and Vasantha Srikantan, contributing to a rich environment of research and innovation.
Conclusion
Judd W. Moul's contributions to prostate cancer research through his patents and collaborations highlight his dedication to advancing medical science. His work continues to pave the way for improved diagnostic and therapeutic options for patients.